2m 2m 2m 2m 2m 2m - S&P 600$1,709.07
2m
TEVA PHARMA IND (TEVA)
NYSE
$42.70-$1.80 (-4.04%)
Price as of Nov 16, 2026 7:01 PM EST- $54.1BMarket Cap
- 75.13%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TEVA PHARMA IND (TEVA)
$42.70-$1.80 (-4.04%)
TEVA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $44.50 | ||
Change | +$0.85 (+1.95%) | ||
Open | $43.91 | ||
High | $44.56 | ||
Low | $43.43 | ||
Previous Close | $43.65 | ||
Volume | 7,562,885 | ||
30-Day Average Volume | 7,244,410 | ||
1-Week Change | 4.44% | ||
1-Month Change | 7.88% | ||
1-Year Change | 75.13% | ||
3-Year Change | 404.54% | ||
5-Year Change | 367.93% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $40.0B | ||
Market Cap | $54.1B | ||
Enterprise Value | $66.8B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | $233.0M | ||
Free Cash Flow | $121.0M | ||
EBIT | $299.0M | ||
EBITDA | $544.0M | ||
Net Working Capital | -$823.0M | ||
EPS | $0.20 | ||
Enterprise Value/EBITDA | 123 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | 223 | ||
PEG | 2 | ||
Price/Free Cash Flow | 447 | ||
Price/Operating Cash Flow | 225 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/27/2017 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 07/01/2004 | ||
Earnings & Revenue